*NEW* Ataxia treatment pipeline launched! It is a visual look at drug development progress. LEARN MORE!

National Ataxia Foundation

Accelerate!

Month: October 2017

2017 Research Drive Kicks Off

Cure Ataxia Research Drive

Join the 2017 Research Drive to Help #CureAtaxia The Annual Ataxia Research Drive began on October 15 with the challenge to raise $400,000 by December 15 to fund the finest Ataxia research. There were 84 research applications submitted to the National Ataxia Foundation for consideration. They are currently being peer-reviewed by 70 leading Ataxia researchers. Read More…


Ataxia Clinical Trial Progresses to 48-Week Extension Phase

Clinical Trial News

BIOHAVEN OPTIMISTIC FOR NEXT PHASE OF TRIAL DESPITE DISAPPOINTING TOPLINE DATA As NAF previously reported, BioHaven Pharmaceutical Holding Company Ltd. recently completed its 8-week trial of dosing for its drug compound trigriluzole. This is the largest clinical trial for Spinocerebellar Ataxia (SCA) to-date. During the 8-week randomization phase, either the compound or a placebo was given Read More…


Translate »